NCT07478926

Flow Detection in Open and Closed Shunt Valve Periods

Detection of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Flow Detection Device During Open and Closed Shunt Periods

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 55 (estimated)
• Sponsor: Rhaeos, Inc. · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is evaluating a new, noninvasive device designed to detect whether cerebrospinal fluid (CSF) is flowing through a surgically implanted shunt. CSF shunts are commonly used to treat hydrocephalus, but it can be difficult to tell whether a shunt is working properly without invasive testing or imaging that does not directly measure flow. The study device is a small, wireless sensor placed on the skin over the shunt tubing, typically near the collarbone. It uses gentle, controlled warmth to measure temperature changes that indicate whether fluid is flowing inside the shunt. The device does not break the skin and does not change a participant's medical care. This study will enroll children and adults who already have a CSF shunt and who do not have new or worsening symptoms of shunt malfunction. All participants will have a measurement taken while their shunt valve is at its usual prescribed setting. Some participants with programmable shunt valves will also have a second measurement taken after their valve is temporarily adjusted to a setting intended to stop or greatly reduce flow ("virtual off"). After this measurement, the valve will be returned to its prescribed setting. The study device results will not be shown to participants or their medical providers and will not be used to make treatment decisions. The goal of the study is to determine how well the device can distinguish between shunts that are allowing flow and those that are not. Participants will be monitored for a short period after device use and, if applicable, after any valve adjustment. The main risks of participation are mild skin irritation from the adhesive or temporary symptoms related to valve adjustment. Participants are not expected to receive a direct medical benefit, but the information gained may help improve future diagnosis of shunt function.

Detailed description

This is a prospective, multicenter, open-label, blinded, observational study designed to evaluate the performance of a noninvasive wireless thermal flow detection device for assessing cerebrospinal fluid (CSF) shunt flow in pediatric and adult patients with hydrocephalus. The study enrolls participants with an existing implanted ventricular CSF shunt who do not have new or worsening symptoms suggestive of shunt malfunction. The investigational device is placed externally on intact skin overlying the shunt tubing, typically near the clavicle, and measures thermal patterns associated with the presence or absence of CSF flow within the shunt catheter. Measurements are obtained using a sponsor-provided tablet application, and results are encoded so that both participants and treating clinicians remain blinded. All participants undergo at least one device measurement with the shunt valve set to the participant's prescribed flow-permissive ("valve normal") setting. A subset of participants with programmable valves capable of being adjusted noninvasively will also undergo an additional measurement after the valve is temporarily adjusted to a manufacturer-reported "virtual off" setting, defined as a valve opening pressure exceeding 400 mm H₂O. After this measurement, the valve is returned to the prescribed setting, with confirmation using standard valve programming tools. Participants whose valves are already prescribed at a "virtual off" setting will undergo a single measurement at that setting. A small number of initial roll-in participants are included to refine procedural logistics; their data are not included in the primary endpoint analyses. The study is non-significant risk. The investigational device does not alter standard-of-care treatment, and device data are not used to guide clinical decision-making. Valve adjustments performed as part of the study are routinely used in clinical care and are monitored closely. Participants are observed for adverse events during device use and for a defined follow-up period after device removal and, when applicable, after valve readjustment. The primary objective of the study is to assess the ability of the device to distinguish between flow-permissive and non-flowing shunts based on known valve settings. Secondary and exploratory objectives include evaluation of device accuracy metrics and characterization of thermal flow patterns under different conditions, such as posture changes or valve transitions. Adverse events, including device-related skin findings and any symptoms associated with valve adjustment, are recorded and reported according to protocol and regulatory requirements. Participants exit the study after completion of the measurement(s) and required observation period.

Conditions

• Hydrocephalus

Interventions

Type	Name	Description
DEVICE	Rhaeos Shunt Monitoring System	characters, and fully aligned with your protocol: The intervention consists of use of a noninvasive, wireless thermal flow detection device to assess cerebrospinal fluid (CSF) flow in an existing implanted shunt. The device is externally applied to intact skin over the shunt tubing, typically near the clavicle, and delivers controlled, imperceptible thermal energy while measuring resulting temperature gradients associated with CSF flow. Measurements are performed using a sponsor-provided tablet application that encodes results to maintain blinding. In some participants with programmable shunt valves, measurements are obtained under both prescribed flow-permissive settings and a temporary manufacturer-reported "virtual off" valve setting, after which the valve is returned to the prescribed setting. Device data are collected for research purposes only and are not used to guide clinical care.

Timeline

• Start date: 2026-01-27
• Primary completion: 2026-12-31
• Completion: 2026-12-31
• First posted: 2026-03-18
• Last updated: 2026-03-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study